combination therapy
In two separate       one-year studies combination therapy with sulphasalazine (SSZ) and methotrexate       (MTX) seemed to offer no benefits compared to either drug used as monotherapy.
In two separate       one-year studies  @SUBJECT$   @PREDICAT$   @OBJECT$  (SSZ) and methotrexate       (MTX) seemed to offer no benefits compared to either drug used as monotherapy.